Disease X and preparing for the next pandemic
Tracks
Track 1
| Thursday, October 31, 2024 |
| 11:00 AM - 11:45 AM |
Details
Harnessing new technologies and opportunities for industry.
Countries around the world have extracted valuable learnings about pandemic preparedness from the COVID-19 pandemic and have seen the phenomenal success of the mRNA vaccine platform. But as we face emerging threats such as Mpox and avian influenza combined with the growth of misinformation and vaccine hesitancy, how well prepared are we for the next pandemic? This panel session will explore the convergence of disciplines required to address future pandemic threats such as vaccine platform development, public health policy, surveillance and globally connected databases, research and manufacturing infrastructure and a social licence to operate.
Speaker
Prof Brendan Crabb
Director and CEO
Burnet Institute
Panellist
Dr Jessica Kaufman
NHMRC Emerging Leadership Fellow, Vaccine Uptake Group
Murdoch Children's Research Institute
Panellist
Prof Jodie McVernon
Director, Doherty Epidemiology
Doherty Institute
Panellist
Dr Craig Rayner
Director, Translational Medicine, Infectious Diseases Development
Moderna (Global)
Chair
Prof. Brett Sutton
Director Health And Biosecurity
CSIRO
Panellist
Victoria Yan
Senior Director, Modular Manufacturing Development
BioNTech
Panellist
